Light-adjustable lens surgery comes to the UK

Article

Ophthalmic surgeon Bobby Qureshi is the first in the UK to implant light-adjustable lenses (LALs), which have the capacity to be altered after surgery to provide the best vision for each individual eye without glasses.

Ophthalmic surgeon Bobby Qureshi is the first in the UK to implant light-adjustable lenses (LALs), which have the capacity to be altered after surgery to provide the best vision for each individual eye without glasses.

What makes the LAL different is the incorporation of unique materials called 'macromers' which were developed by Calhoun Vision Inc in the USA led by a team of Nobel Prize winning scientists. The macromers are designed to be sensitive to harmless ultraviolet light of a specific wavelength. When this light is shone into the eye the macromers link together in a very controlled and specific way called photopolymerisation.

After implantation of the lens the patient's vision is evaluated when the eye has healed, typically at about 2 weeks. Any adjustment required to perfect the vision is carried out at this time with the patient seated comfortably at the digital light delivery device, a machine designed to deliver the exact dose and profile of light onto the LAL to correct any residual errors.

Light adjustability of the lens is based on the principles of photochemistry and diffusion whereby components incorporated into the lens matrix are photopolymerised on exposure to the UV light.

This means that the light affects the macromers to cause very specific swelling or thinning of the lens implant changing the focus to give the patient the best vision possible for their eye. The process takes less than 2 minutes and can be repeated for further adjustment if required. Once the desired prescription is achieved further UV light is passed through the lens to 'fix' it in position to make the adjustment permanent.

Commenting on the technique, Qureshi told the BBC: “The beauty about the lens is that from the start it was designed so the shape of the lens could be changed from the outside by using light from a particular wavelength,” he said.

“By changing the shape you can change the focus so you can change long-sightedness, short-sightedness and astigmatism (blurring).

“Unlike a conventional lens you can almost guarantee 20/20 vision because you can change and make sure you have corrected any problems.”

More...

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.